This information was published on 2024-09-27T10:06:25 for IP Right Registration Published.
| Field | Value |
| (210) | 2443751 (IR 1785553) |
| (220) |
19 Feb 2024
|
| (511) (510) |
Class 5
Biopharmaceuticals; pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of the following specific list of enumerated indications, autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders, diseases, conditions and disorders associated with misfolded proteins, diseases, conditions and disorders affecting the central nervous system, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host/graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes. Class 42 Research services in the field of biotechnology. Class 45 Licensing of intellectual property in the field of biotechnology. |
| (540) | PROTHENA |
| (550) | Word |
| (730) |
Prothena Corporation plc
|
Find out more about publications on the About page.